Elizabeth E Reed, Chief Legal Officer and General Counsel, on April 13, 2026, sold 51,500 shares in Travere Therapeutics (TVTX) for $2,126,452. Following the Form 4 filing with the SEC, Reed has control over a total of 105,211 common shares of the company, with 105,211 shares held directly.
SEC Filing:
David Spector, Director, Chairman & CEO, on April 14, 2026, sold 10,000 shares in Pennymac Financial Services (PFSI) for $928,279. Following the Form 4 filing with the SEC, Spector has control over a total of 600,005 common shares of the company, with 529,401 shares held directly and 70,604 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1745916/000174591626000115/xslF345X05/form4.xml
Richard H Lenny, Director, on April 14, 2026, executed a purchase for 25,000 shares in Conagra Brands (CAG) for $358,500. Following the Form 4 filing with the SEC, Lenny has control over a total of 229,340 common shares of the company, with 229,340 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/23217/000113949726000002/xslF345X05/form4-04152026_090402.xml
John J Mulligan, Director, on April 14, 2026, executed a purchase for 17,500 shares in Conagra Brands (CAG) for $250,402. Following the Form 4 filing with the SEC, Mulligan has control over a total of 20,728 common shares of the company, with 20,728 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/23217/000154581926000009/xslF345X05/form4-04152026_090422.xml